Expression Levels of FOXO-1, P27KIP1, MIR-27, MIR-186 and AKT1/AKT-P Proteins in Women with Endometrial Cancer and Hyperplasia: Implications for the Human Reproductive System
Author:
- 1 January 2023
- journal article
- editorial
- Published by ACTA Endocrinologica Foundation in Acta Endocrinologica (Bucharest)
- Vol. 19 (1) , 1-9
Abstract
Despite extensive research on endometrial cancer (EC) and endometrial hyperplasia, there is still a gap in understanding the molecular mechanisms underlying their development and progression. The aim of this study was to investigate the expression levels of FOXO-1, P27Kip1, miR-27, and miR-186, and Akt1, Akt-P proteins in patients with EC and endometrial hyperplasia compared to control subjects. Samples of the endometrial tumor (n=30), normal (control) (n=30) and endometrial hyperplastic (n=30) tissue were obtained from patients referring to Arash and Imam Khomani hospitals, Tehran, Iran. Expression levels of genes and microRNAs were evaluated by qRT- PCR. Western blot analysis was applied for protein evaluation. The data were analyzed using t-test, Mann -Whitney U, Pearson correlation coefficient analysis, ANCOVA and ANOVA. There was significant decrease in FOXO-1 in EC tissue compared to control tissue (pKip1 expression level did not significantly change in patients with EC and hyperplasia. There was a significant association between expression levels of miR-27 with FOXO-1 and P27Kip1 in patients with EC. Western blot analysis revealed higher endometrial AKT1-P protein levels in patients with EC and hyperplasia than control subjects (p<0.05). Our findings suggest that FOXO-1, miR-27, miR-186, and Akt1-P/Akt1 protein have the potential to serve as tissue biomarkers for early diagnosis, prognosis, and progression of EC in the human reproductive system.Keywords
This publication has 33 references indexed in Scilit:
- Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancerOncology Letters, 2013
- Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancerCancer Science, 2011
- MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review)Oncology Letters, 2010
- Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial CancerCancer Research, 2010
- Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1Gynecologic Oncology, 2009
- MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3′-Untranslated Region of the Gene That Decrease Steady-state Levels of the TranscriptJournal of Biological Chemistry, 2008
- The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial CarcinomaEndocrinology, 2007
- Concomitant activation of AKT with extracellular‐regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosissCancer Science, 2007
- Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cellsOncogene, 2007
- Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient MiceJournal of Biological Chemistry, 2004